Melvin L.K. Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at the National Cancer Centre Singapore, shared a post on LinkedIn:
“ASTRO 2025 in San Francisco.
Huge congrats to the American Society for Radiation Oncology (ASTRO) for another successful 67th Annual meeting.
Been 3 years since my last meeting, and it was an absolute thrill to catch up with colleagues who hadn’t changed one bit.
Busy few days with key highlights on
- Speaking on the role of Radiotherapy in the treatment of metastatic disease with a powerful line-up of global luminaries
- Sharing our work with ArteraAI Andre Esteva, PhD, on advancing diagnostics for Prostate Cancer in Singapore, validating their FDA-approved MMAI test in a local population – Huge win to get such next-gen diagnostics to AsiaPacific
- Also managed to visit Osyter Point to advise a new biotech on their pipeline development
- Witnessing a long-time colleague, Prof Quynh Le from Stanford, who was awarded the ASTRO Gold Medal – What a landmark achievement for HeadNeckCancer
- Finally catching up with so many old colleagues who remain committed to advancing the field of Radiation Oncology, we are all like-minded in this fight against cancer.
Hopefully see you all in Boston 2026!”
More posts featuring Melvin L.K. Chua.
